Abstract
Background
Intracranial hemorrhage (ICH) is a frequent complication in patients with an implanted left ventricular assist device (LVAD) for advanced heart failure. Bloodstream infection is known to be associated with ICH in patients with LVAD, but its effects on ICH-associated mortality are unknown. We compared characteristics and mortality of infection-associated, traumatic, and spontaneous hemorrhages.
Methods
Patients in an LVAD registry at a tertiary care center were reviewed for this cohort study. ICH included intraparenchymal hemorrhage, subarachnoid hemorrhage, and subdural hemorrhage. Hemorrhages were categorized into infectious, traumatic, and spontaneous by the presence or absence of concurrent device-associated infection or antecedent trauma.
Results
Of 683 patients with an LVAD, 73 experienced ICH (10.7%). Intraparenchymal hemorrhage was the most prevalent (72%), followed by subarachnoid hemorrhage (27%) and subdural hemorrhage (23%), with multiple concurrent hemorrhage subtypes in 16 patients (22%). Median time from implantation to ICH was shorter in spontaneous ICH than in infection-associated ICH (100 days vs. 252 days, p = 0.048). The prevalence of the different subtypes of ICH were similar between spontaneous and infection-associated ICH, and no differences were seen in mortality between the different causes of ICH.
Conclusions
Although spontaneous ICH occurred earlier after LVAD implantation than infection-associated ICH, no difference in mortality was seen between the different causes of ICH.
Similar content being viewed by others
References
Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43. https://doi.org/10.1056/NEJMoa012175.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H. Stroke risk and mortality in patients with ventricular assist devices. Stroke. 2016;47(11):2702–6. https://doi.org/10.1161/STROKEAHA.116.014049.
Acharya D, Loyaga-Rendon R, Morgan CJ, et al. INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes. JACC Hear Fail. 2017;5(10):703–11. https://doi.org/10.1016/j.jchf.2017.06.014.
Tahir RA, Rotman LE, Davis MC, et al. Intracranial hemorrhage in patients with a left ventricular assist device. World Neurosurg. 2018;113:e714–21. https://doi.org/10.1016/j.wneu.2018.02.135.
Wilson TJ, Stetler WR, Al-Holou WN, Sullivan SE, Fletcher JJ. Management of intracranial hemorrhage in patients with left ventricular assist devices: clinical article. J Neurosurg. 2013;118(5):1063–8. https://doi.org/10.3171/2013.1.JNS121849.
Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Hear Lung Transplant. 2017;36(6):673–83. https://doi.org/10.1016/j.healun.2016.12.010.
O’Horo JC, Saleh OMA, Stulak JM, Wilhelm MP, Baddour LM, Sohail MR. Left ventricular assist device infections: a systematic review. ASAIO J. 2018;64(3):287–94. https://doi.org/10.1097/MAT.0000000000000684.
Chukwudelunzu FE, Brown RD, Wijdicks EFM, Steckelberg JM. Subarachnoid haemorrhage associated with infectious endocarditis: case report and literature review. Eur J Neurol. 2002;9(4):423–7. https://doi.org/10.1046/j.1468-1331.2002.00432.x.
Cho SM, Moazami N, Katz S, Bhimraj A, Shrestha NK, Frontera JA. Stroke risk following infection in patients with continuous-flow left ventricular assist device. Neurocrit Care. 2019;31(1):72–80. https://doi.org/10.1007/s12028-018-0662-1.
Teuteberg JJ, Cleveland JC, Cowger J, et al. The Society of Thoracic Surgeons Intermacs 2019 annual report: the changing landscape of devices and indications. Ann Thorac Surg. 2020;109(3):649–60. https://doi.org/10.1016/j.athoracsur.2019.12.005.
Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32(4):891–6. https://doi.org/10.1161/01.str.32.4.891.
Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304–5. https://doi.org/10.1161/01.STR.27.8.1304.
Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59(1):21–6. https://doi.org/10.1227/01.NEU.0000218821.34014.1B.
Molina EJ, Shah P, Kiernan MS, et al. The society of thoracic surgeons intermacs 2020 annual report. Ann Thorac Surg. 2021;111(3):778–92. https://doi.org/10.1016/J.ATHORACSUR.2020.12.038.
Cho SM, Lee T, Starling RC, Thompson NR, Uchino K. The impact of infection and elevated INR in LVAD-associated intracranial hemorrhage: a case-crossover study. ASAIO J. 2019;65(6):545–50. https://doi.org/10.1097/MAT.0000000000000887.
Aggarwal A, Gupta A, Kumar S, et al. Are blood stream infections associated with an increased risk of hemorrhagic stroke in patients with a left ventricular assist device? ASAIO J. 2012;58(5):509–13. https://doi.org/10.1097/MAT.0b013e318260c6a6.
Rahal A, Ruch Y, Meyer N, et al. Left ventricular assist device-associated infections: incidence and risk factors. J Thorac Dis. 2020;12(5):2654–62. https://doi.org/10.21037/jtd.2020.03.26.
Sharma V, Deo SV, Stulak JM, et al. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg. 2012;94(5):1381–6. https://doi.org/10.1016/j.athoracsur.2012.05.074.
Murase S, Okazaki S, Yoshioka D, et al. Abnormalities of brain imaging in patients after left ventricular assist device support following explantation. J Hear Lung Transplant. 2020;39(3):220–7. https://doi.org/10.1016/j.healun.2019.11.019.
Yoshioka D, Okazaki S, Toda K, et al. Prevalence of cerebral microbleeds in patients with continuous-flow left ventricular assist devices. J Am Heart Assoc. 2017;6(9): e005955. https://doi.org/10.1161/JAHA.117.005955.
Morris AA, Pekarek A, Wittersheim K, et al. Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device. J Hear Lung Transplant. 2015;34(12):1570–7. https://doi.org/10.1016/j.healun.2015.08.013.
Teuteberg JJ, Slaughter MS, Rogers JG, et al. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies. JACC Hear Fail. 2015;3(10):818–28. https://doi.org/10.1016/j.jchf.2015.05.011.
Cho SM, Starling RC, Teuteberg J, et al. Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials. J Hear Lung Transplant. 2020;39(7):639–47. https://doi.org/10.1016/j.healun.2020.01.1330.
Markham DW, Fu Q, Palmer MD, et al. Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices. Circ Hear Fail. 2013;6(2):293–9. https://doi.org/10.1161/CIRCHEARTFAILURE.112.969873.
Cornwell WK, Tarumi T, Aengevaeren VL, et al. Effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with left ventricular assist devices. J Hear Lung Transplant. 2014;33(12):1295–303. https://doi.org/10.1016/j.healun.2014.08.013.
Fudim M, Rogers JG, Frazier-Mills C, Patel CB. Orthostatic hypotension in patients with left ventricular assist devices: acquired autonomic dysfunction. ASAIO J. 2018;64(3):e40–2. https://doi.org/10.1097/MAT.0000000000000640.
Raasch H, Jensen BC, Chang PP, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164(3):373–8. https://doi.org/10.1016/j.ahj.2012.06.018.
Funding
This study received no funding.
Author information
Authors and Affiliations
Contributions
AS: conception and design, acquisition and interpretation of data, and drafting the article. CH: conception and design, interpretation of data, and revising the article. AG: conception and design, interpretation of data, and revising the article. RCS: conception and design, interpretation of data, and revising the article. JDE: conception and design, interpretation of data, and revising the article. MZYT: conception and design, interpretation of data, and revising the article. S-MC: conception and design, interpretation of data, and revising the article. KU: conception and design, interpretation of data, and revising the article. The final manuscript was approved by all authors.
Corresponding author
Ethics declarations
Conflicts of interest
Ken Uchino serves on the data safety monitoring board of a study of LVAD device sponsored by Evaheart, Inc. Other authors have no conflicts to disclose.
Ethical approval/informed consent
This study adhered to ethical guidelines and was approved by the local institutional review board (Cleveland Clinic institutional review board number 17-363).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shoskes, A., Hassett, C., Gedansky, A. et al. Implications of Causes of Intracranial Hemorrhage During Left Ventricular Assist Device Support. Neurocrit Care 37, 267–272 (2022). https://doi.org/10.1007/s12028-022-01494-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-022-01494-3